Page last updated: 2024-10-24

caffeine and Porphyria Cutanea Tarda

caffeine has been researched along with Porphyria Cutanea Tarda in 1 studies

Porphyria Cutanea Tarda: An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bulaj, ZJ1
Franklin, MR1
Phillips, JD1
Miller, KL1
Bergonia, HA1
Ajioka, RS1
Griffen, LM1
Guinee, DJ1
Edwards, CQ1
Kushner, JP1

Other Studies

1 other study available for caffeine and Porphyria Cutanea Tarda

ArticleYear
Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda.
    The Journal of laboratory and clinical medicine, 2000, Volume: 136, Issue:6

    Topics: Administration, Cutaneous; Adult; Caffeine; Case-Control Studies; Cytochrome P-450 CYP1A2; Estrogen

2000